Abstract:Objective To investigate the clinical manifestations,diagnostic methods and treatment of severe combined immunodeficiency (SCID).Methods The patient presented at the age of 2 months with frequent pneumonia and a history of chronic oral candidiasis even when treated adequately with antibiotics or anti-fungi agents. Flow cytometric analysis was used to assess T cells. Cell surface markers of peripheral blood cells were determined by immunofluorescent staining and flow cytometry with antibodies purchased from BD company. IL-2R gene was analyzed by PCR and sequence was performed for the patient and partial maternal family members. Clinical documented information of the patient and his uncle died during early life was reviewed. His peripheral blood mononuclear cells were incubated at 37 ℃ in complete culture medium RPMI-1640. Cells were incubated in round bottom tissue culture plates with PHA for 72 h, and 18-20 hours before termination of the culture, thymidine was added to each well. The cells were then harvested and samples were counted in a liquid scintillation counter.Results The patient had a very low T-cell number. Initial investigations revealed a total white blood cell count of 2.8×109·L-1 [reference range, (5.4-9.4)×109·L-1] with a lymphocyte count of 1.9×109·L-1 [reference range, (2.8-5.7)×109·L-1], the results of flow cytometric analysis showed CD3+0, CD4+0, CD8+0, CD19+ 95%, CD16+CD56+ 4%. Sequencing of his IL-2RG revealed a G deletion at 849 in exon 6, the consequence showed frameshift start form cysteine 278, "TGA" stop codon created at position 293. His mother was confirmed to be a carrier, she didn't seem to be a simple heterozygote,but maybe mosaic mutation with mixed population in leucocytes. His uncle died of severe incurable infection and without mononuclear proliferation to PHA stimulation. He presented hyperpyrexia, rash and splenohepatomegalia after recieving transfusion of untreated fresh blood. Considering his family history, his uncle's clinical manifestation was high likely due to graft versus host disease. IL2R gene analysis was also done for his newborn sister after family survey.His sister was confirmed to be the same mutation as her mother.Conclusions Genetic diagnosis was made for one X-SCID patient caused by IL-2RG. And after family survey, his mother and sister were confirmed to be carriers, maybe mosaic mutation with mixed population in leucocytes. Infant with severe infection even after treated with adequate standard treatment, should be considered the possibility of suffering SCID and immune function evaluation should be taken. As the underlying severe disorders, the living vaccine and untreated blood products transfusion must be restrained. Early immune reconstitution including bone marrow or stem cell transplantation offers the best chance of long-term survival. Medical workers should pay more attention to immunodeficiency.

CD3+ T cells in severe combined immune deficiency (scid) mice. I. Transferred purified CD4+ T cells, but not CD8+ T cells are engrafted in the spleen of congenic scid mice

CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells

[Advances in Newborn Screening and Immune System Reconstitution of Severe Combined Immunodeficiency].

Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated Rag2 and IL2rg Mutation

[Hematopoietic Repopulating Ability of Human CD34+ Cells and CD34- Cells in NOD/SCID Mice].

Genetically-determined defects of T cell development

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy

Lymphohemopoietic reconstitution using wheat germ agglutinin-positive hemopoietic stem cell transplantation within but not across the major histocompatibility antigen barriers

Improved B cell development in humanized NOD -scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3

Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency

Dclre1c-Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research

Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes

Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells

Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene

1225 NCG-SGM3 Humanized Mice – an Ideal Model for Human Immune Reconstitution of T and Myeloid Cell Lineages

Bone marrow transplantation for the treatment of immune deficiency states

Identification of a Highly Functional Effector CD8+ T Cell Program After Transplantation in Mice and Humans

Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency

A report of two cases of severe X-linked combined immunodeficiency in one family and literature review